Skip to content

Canine-assisted Psychotherapy Motivation Alliance

Effects of the Inclusion of a Dog in Psychotherapy on Children's Alliance and Treatment Motivation

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05384808
Acronym
CAP
Enrollment
150
Registered
2022-05-20
Start date
2022-06-01
Completion date
2028-12-31
Last updated
2024-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alliance, Therapeutic, Motivation

Brief summary

The aim of the study is to investigate the needed extent and the way a dog is integrated into psychotherapeutic interventions for them to be motivating and alliance building for children and adolescents with psychiatric disorders aged 9 to 17 years old. Specifically, we want to elaborate if the dog needs to be integrated into the therapy in a form that it is part of the therapeutic context or if the presence of the dog without being part of the therapeutic context per se is beneficial.

Interventions

Participants receive a standard psychotherapy session with no dog being present.

BEHAVIORALCanine-assisted psychotherapy with dog actively integrated.

A dog is present and actively integrated into the therapeutic narrative.

BEHAVIORALCanine-assisted psychotherapy with dog passively integrated.

A dog is present but not actively integrated into the therapeutic narrative.

Sponsors

University of Basel
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
9 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

for children and adolescents: : * Age between 9 and 17 years * Children are seeing the therapist for the first time * Basic knowledge of child and parents in either German or English to be able to fill in questionnaires * Informed consent given by legal guardian * Positive or neutral attitude towards dogs

Exclusion criteria

for children and adolescents: : * acute psychosis; early childhood autism * diagnosed developmental disorder or intellectual delay; if not diagnosed, exclusion when questionnaires cannot be completed due to development level * fear of dogs * allergic reactions to dogs * reported aggressive behavior towards animals in the past Inclusion criteria for therapists: * working with an own therapy dog * completed therapy training or if not completed far advanced therapy training under supervision * working with children and adolescents aged 9 to 17 years

Design outcomes

Primary

MeasureTime frameDescription
Therapeutic alliance of patients9 weeksPatient's reported therapeutic alliance is measured after the first, the third and the fifth therapy session of a newly began psychotherapy using the german adaptation of the Therapeutic Alliance Scales for Children (TASC). The TASC consists of 12 items, answered with a 4 point likert scale. The questionnaire assesses the therapeutic alliance from the perception of the child. Four weeks after the fifth therapy session children will be asked to fill in the questionnaire again as follow-up measurement.
Motivation of patients9 weeksPatient's reported motivation is measured after the first, the third and the fifth therapy session of a newly began psychotherapy using the Situational Motivation Scale for children (SMS-15). The SMS-15 consists of 15 items answered with a 7 point likert scale. Four weeks after the fifth therapy session, children will be asked to fill in the questionnaire again as follow-up measurement.

Secondary

MeasureTime frameDescription
Treatment satisfaction of patients4 weeksTreatment satisfaction of children is measured after the fifth therapy session as well as four weeks after as follow up using the treatment assessment questionnaire (FBB). The FBB consists of 20 items answered with a 5 point likert scale.
Number of missed sessions5 weeksNumber of missed sessions and drop-outs will be documented for each child participating in the study.

Countries

Switzerland

Contacts

Primary ContactKarin Hediger, Prof. Dr.
karin.hediger@unibas.ch(+41) 61 207 69 58
Backup ContactWanda Arnskötter, Msc.
wanda.arnskoetter@unibas.ch

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026